| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2006 | EP1651608A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651606A2 Pyridyl derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651605A2 Pyridyl derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651602A2 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 05/03/2006 | EP1651601A1 Stable modifications of tegaserod hydrogen maleate |
| 05/03/2006 | EP1651600A2 Novel n -substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651271A2 Compositions and methods for treating coronavirus infection and sars |
| 05/03/2006 | EP1651270A1 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 05/03/2006 | EP1651259A2 Methods and compositions for producing antigenic responses |
| 05/03/2006 | EP1651255A1 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 05/03/2006 | EP1651251A2 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 05/03/2006 | EP1651246A2 Method for promoting bone growth |
| 05/03/2006 | EP1651245A1 A composition for decreasing the risk of long-haul traveller's syndrome comprising a mixture of pycnogenol and standardized ginger root extract |
| 05/03/2006 | EP1651242A2 Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation |
| 05/03/2006 | EP1651241A2 Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds |
| 05/03/2006 | EP1651239A1 Intravascular delivery of non-viral nucleic acid |
| 05/03/2006 | EP1651238A1 Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
| 05/03/2006 | EP1651237A2 Methods for treatment of dermatological conditions |
| 05/03/2006 | EP1651236A1 Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation |
| 05/03/2006 | EP1651235A2 Sigma-1 receptor ligand with acetylcholinesterase inhibition properties |
| 05/03/2006 | EP1651234A1 Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders |
| 05/03/2006 | EP1651233A2 Pharmaceutical composition |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1651231A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 05/03/2006 | EP1651230A1 Medicaments for inhalation comprising steroids and a novel anticholinergic |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1651228A1 Use of quinazoline tyrosine kinase inhibitors in the treatment of inflammatory processes |
| 05/03/2006 | EP1651227A1 Combination therapy |
| 05/03/2006 | EP1651226A2 Ubiquitin ligase inhibitors and methods related thereto |
| 05/03/2006 | EP1651225A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 05/03/2006 | EP1651224A1 Medicaments for inhalation comprising anticholinergics and a betamimetic |
| 05/03/2006 | EP1651222A1 Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders |
| 05/03/2006 | EP1651221A1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| 05/03/2006 | EP1651219A2 Aripiprazole and haloperidol pamoate salts |
| 05/03/2006 | EP1651218A1 Fexofenadine composition and process for preparing |
| 05/03/2006 | EP1651217A1 Alkaline salts of proton pump inhibitors |
| 05/03/2006 | EP1651216A2 Infection prophylaxis using immune response modifier compounds |
| 05/03/2006 | EP1651215A1 Transdermaltherapeutic system containing a pramipexol active agent |
| 05/03/2006 | EP1651213A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 05/03/2006 | EP1651211A2 Combination of drugs for the treatment of neoplasms |
| 05/03/2006 | EP1651210A1 Dispersible formulation of an anti-inflammatory agent |
| 05/03/2006 | EP1651209A2 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651208A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| 05/03/2006 | EP1651207A2 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 05/03/2006 | EP1651206A1 Compositions and methods for treating gastrointestinal conditions |
| 05/03/2006 | EP1651205A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 05/03/2006 | EP1651202A1 Compositions containing prodrugs of florfenicol and methods of use |
| 05/03/2006 | EP1651201A1 Necrosis avid tracer agent |
| 05/03/2006 | EP1651199A1 Method and preparation for reducing irritation and/or inflammatory reaction in human skin |
| 05/03/2006 | EP1651198A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 05/03/2006 | EP1651197A1 Transdermal warfarin-containing delivery system |
| 05/03/2006 | EP1651196A2 Tamper-resistant transdermal dosage form comprising an active component and an adverse agent component and an adverse agent component at the distal site of the active agent layer |
| 05/03/2006 | EP1651195A2 Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 05/03/2006 | EP1651194A1 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 05/03/2006 | EP1651193A2 Pharmaceutical compositions having a swellable coating |
| 05/03/2006 | EP1651191A2 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 05/03/2006 | EP1651190A2 Formulations containing an immune response modifier |
| 05/03/2006 | EP1651189A1 Novel metaxalone compositions |
| 05/03/2006 | EP1651188A2 Particles containing an active agent in the form of a co-precipitate |
| 05/03/2006 | EP1651186A1 Macrolides containing oil-in-water emulsions |
| 05/03/2006 | EP1651184A1 Fast dissolving orally consumable films containing pharmaceutically active agents |
| 05/03/2006 | EP1651176A2 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 05/03/2006 | EP1651175A1 Use of spermine and/or spermidine against skin ageing in dietary, pharmaceutical or cosmetic compositions |
| 05/03/2006 | EP1651170A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 05/03/2006 | EP1651168A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 05/03/2006 | EP1651167A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 05/03/2006 | EP1651164A2 Composition and method for treating neurological disorders |
| 05/03/2006 | EP1651162A2 Improved cytotoxic agents comprising new maytansinoids |
| 05/03/2006 | EP1651137A1 Osmium compounds for reduction of adverse inflammation |
| 05/03/2006 | EP1572665B1 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/03/2006 | EP1572178B1 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1545496A4 Nutritional supplement for adolescents |
| 05/03/2006 | EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis |
| 05/03/2006 | EP1501530A4 Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | EP1499606B1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 05/03/2006 | EP1499590B1 Piperidine derivatives as potassium channel blockers |
| 05/03/2006 | EP1492517B1 Hot melt tts for administering rotigotine |
| 05/03/2006 | EP1490049B1 Citalopram for the treatment of elevated blood pressure |
| 05/03/2006 | EP1467724B1 Orodispersible pharmaceutical composition comprising agomelatine |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1450788B8 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/03/2006 | EP1427724B1 Novel use of substituted aminomethyl chromans |
| 05/03/2006 | EP1425046A4 Wild-type ras as a cancer therapeutic agent |
| 05/03/2006 | EP1425005B1 Pharmaceutical compostion comprising lumiracoxib |
| 05/03/2006 | EP1390351B1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |